Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy

被引:0
作者
Silke Cameron
Diana Hünerbein
Tümen Mansuroglu
Thomas Armbrust
Jens-Gerd Scharf
Harald Schwörer
László Füzesi
Giuliano Ramadori
机构
[1] University Clinic of the Georg August University,Department of Gastroenterology and Endocrinology
[2] University Clinic of the Georg August University,Department of Gastroenteropathology
来源
BMC Cancer | / 9卷
关键词
Overall Survival; Bevacizumab; Cetuximab; Folinic Acid; Palliative Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 201 条
  • [1] Martin ES(2007)Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types Cancer Res 67 10736-10743
  • [2] Tonon G(2005)Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases Br J Surg 92 1155-1160
  • [3] Sinha R(2007)Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 14 766-770
  • [4] Xiao Y(2000)Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group BMJ 321 531-535
  • [5] Feng B(2008)Advances in chemotherapy against advanced or metastatic colorectal cancer Digestion 77 13-22
  • [6] Kimmelman AC(2008)Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer 8 120-127
  • [7] Protopopov A(2008)Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials J Clin Oncol 26 1443-1451
  • [8] Ivanova E(2007)Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study BMC Cancer 7 91-758
  • [9] Brennan C(2007)First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer Cancer 110 752-3815
  • [10] Montgomery K(2007)Metastatic colorectal cancer-past, progress and future World J Gastroenterol 13 3806-2005